Danimer Scientific (DNMR) Tops Q3 EPS by 16c

Danimer Scientific (NYSE: DNMR) reported Q3 EPS of $0.08, $0.16 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $13.4 million versus the consensus estimate of $14.56 million.

Business Outlook:

The Company expects to continue its acceleration of investments in headcount, inclusive of Novomer, to build out the operational platform and infrastructure needed to support its production capacity expansion and sales growth objectives. The Company continues to expect that improved operating rates will contribute to Adjusted EBITDA and cash flow from operations. Based on the timing of customer product launches, the Company continues to expect its second half 2021 revenue to be weighted towards the fourth quarter. The Company now expects full year capital expenditures to be in the range of $200 million to $210 million mainly due to the accelerated groundbreaking of the Company’s greenfield facility in Bainbridge, Georgia as well as phase II construction moving faster than previously anticipated.

For earnings history and earnings-related data on Danimer Scientific (DNMR) click here.

You May Also Be Interested In

• Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
• McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance
• Forum Markets, Incorporated (FRMM) Tops Q2 EPS by 29c ; Offers Guidance